Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

17 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-17/original-research-formycon-ag-von-first-berlin-equity-research-gmbh

17 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-17/horus-pharma-becomes-additional-commercialization-partner-for-formycons-eylea-biosimilar-fyb203-in

13 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-13/formycon-confirms-full-year-guidance-following-business-development-in-line-with-plan-working-capi

20 Feb 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-02-20/formycon-presents-clinical-data-on-ustekinumab-biosimilar-fyb202-at-the-ecco-congress-in-berlin

05 Feb 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-02-05/lotus-pharmaceutical-becomes-strategic-partner-for-the-commercialization-of-formycon-s-eylea-biosim

13 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/13/3008103/0/en/Teva-Announces-Collaboration-to-Commercialize-Formycon-s-Biosimilar-Candidate-to-Eylea-aflibercept-in-major-parts-of-Europe-and-in-Israel.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE